Home β€Ί Stock analysis β€Ί TIL

Instil Bio (TIL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

TIL slides 3.6% to $5.91, a 52-week low. Closed at $5.91, -3.59% vs the prior close of $6.13. Day range $5.91–$6.45, opened at $6.18.

Last close$5.91-3.59%
Day range5.91–6.45
Open6.18
Volume25.17K
52-week range5.67–21.64
Avg volume (20d)22.90K

TIL daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” TIL slides 3.6% to $5.91, a 52-week low
Oct 15, 2026 β€” TIL jumps 3.0% to $6.13 on 2.3x normal volume
Oct 14, 2026 β€” TIL slides 3.7% to $5.95, a 52-week low on 3.2x normal volume
Oct 13, 2026 β€” TIL slides 6.1% to $6.18, a 52-week low on 2.1x normal volume
Oct 12, 2026 β€” TIL dips 2.4% to $6.58
Oct 9, 2026 β€” TIL rises 2.7% to $6.74 on 3.0x normal volume
Oct 8, 2026 β€” TIL slides 4.9% to $6.56, a 52-week low on 4.7x normal volume
Oct 7, 2026 β€” TIL ends flat (+0.2%) to $6.90
Oct 6, 2026 β€” TIL dips 0.9% to $6.89, a 6-month low on 2.1x normal volume
Oct 5, 2026 β€” TIL slides 3.7% to $6.95, a 6-month low, 3 down days in a row
Oct 2, 2026 β€” TIL ends flat (-0.2%) to $7.22 on 2.6x normal volume

TIL latest news & SEC filings

Every SEC filing by or about TIL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Aug 13, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001789769-26-000057

Aug 13, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001789769-26-000055

Things to know before you trade TIL

TIL market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20266.186.455.915.9125.17K
Oct 15, 20266.086.496.086.1333.00K
Oct 14, 20266.066.225.935.9544.10K
Oct 13, 20266.616.616.036.1827.60K
Oct 12, 20266.656.666.516.5811.30K
Oct 9, 20266.696.766.536.7437.60K
Oct 8, 20266.846.896.416.5654.50K
Oct 7, 20266.897.006.856.907.30K
Oct 6, 20267.227.226.826.8924.20K
Oct 5, 20267.227.356.956.9512.90K
Oct 2, 20267.197.447.157.2228.60K
Oct 1, 20267.157.307.137.245.20K
Sep 30, 20267.197.397.147.248.70K
Sep 29, 20267.047.237.047.144.10K
Sep 28, 20267.117.167.037.0411.60K
Sep 25, 20267.057.177.057.179.50K
Sep 24, 20267.147.247.057.128.40K
Sep 23, 20267.037.387.037.2411.40K
Sep 22, 20267.027.207.007.1323.90K
Sep 21, 20267.097.206.927.0769.00K

About Instil Bio

Instil Bio (TIL) is listed on the Nasdaq and classified by the SEC under β€œBiological Products, (No Diagnostic Substances)”. Its business address is in DALLAS, TX. State of incorporation: NY. Fiscal year ends December 31. SEC CIK 1789769.

TIL board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Gwendolyn BinderDirectorJun 12, 2026
Neil W GibsonDirectorJun 12, 2026
George MatchamDirectorJun 12, 2026
R Kent Jr McgaughyDirectorJun 12, 2026

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

TIL financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$-71.37M-10.70$-36.62M
Dec 31, 2024β€”$-74.14M-11.39$-55.70M
Dec 31, 2023β€”$-156.09M-24.00$-82.03M
Dec 31, 2022β€”$-223.18M-34.46$-180.16M
Dec 31, 2021$0$-156.79M-1.48$-122.14M

Latest balance sheet: total assets $197.71M, total liabilities $90.33M, cash $5.54M (as of Jun 30, 2026).

TIL earnings / results-day log

DateFilingClose that day
Aug 13, 20268-K Item 2.02 (results)$7.27
May 15, 20268-K Item 2.02 (results)$8.07
Mar 27, 20268-K Item 2.02 (results)$7.79
Nov 13, 20258-K Item 2.02 (results)$13.91
Aug 13, 20258-K Item 2.02 (results)$26.97
May 13, 20258-K Item 2.02 (results)$12.74
Mar 4, 20258-K Item 2.02 (results)$17.50
Nov 13, 20248-K Item 2.02 (results)$31.54
Aug 13, 20248-K Item 2.02 (results)β€”
May 10, 20248-K Item 2.02 (results)β€”
Mar 21, 20248-K Item 2.02 (results)β€”
Nov 13, 20238-K Item 2.02 (results)β€”

Related stocks Β· Biological Products, (No Diagnostic Substances)

Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on TIL

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.